Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3039183	s-clteabg	— (—)	52	55	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Immunodeficiency with predominantly antibody defects

+∞

10.43

1.1

0.0

—

ILD medications

5.42

9.75

1.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

5.59

9.33

1.0

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6.05

8.97

1.2

1.0

—

6.05

8.97

1.2

1.0

—

First line medication for Crohn's disease

5.18

8.95

1.0

1.1

—

Certain disorders involving the immune mechanism

24.02

8.90

1.2

1.0

—

Other diseases of upper respiratory tract

6.13

8.86

1.0

1.1

—

Chronic sinusitis

11.53

8.55

1.1

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4.93

8.24

1.2

1.0

—

Asthma (mode)

16.07

8.20

1.0

—

Asthma

15.73

8.09

1.0

—

Asthma, excluding more controls

15.65

8.07

1.0

—

Certain infectious and parasitic diseases

5.95

8.05

1.0

—

Asthma (only as main-diagnosis)

16.21

7.90

1.0

—

Other pulmonary diagnosis

15.03

7.86

1.0

—

Asthma (only as main-diagnosis), excluding more controls

16.01

7.84

1.0

—

Influenza and pneumonia

4.45

7.53

1.1

1.0

—

General symptoms and signs

4.78

7.33

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

4.52

7.32

1.0

1.1

—

Nonhereditary hypogammaglobulinemia

+∞

7.31

1.1

0.0

—

Diseases of oesophagus, stomach and duodenum

4.60

7.25

1.0

1.1

—

Acute upper respiratory infections

4.68

7.11

1.1

1.0

—

All pneumoniae

4.31

7.06

1.2

1.0

—

Pneumonia, organism unspecified

4.51

6.80

1.2

1.0

—

Acute sinusitis

6.73

6.74

1.1

1.0

—

Chronic lower respiratory diseases

4.04

6.60

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

7.77

6.59

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

13.03

6.56

1.0

—

COPD differential diagnosis

13.03

6.56

1.0

—

ILD differential diagnosis

13.02

6.56

1.0

—

Kela reimbursement Agammaglobulinemia (D80-84)

+∞

6.27

1.3

0.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

18.01

6.26

1.1

1.0

—

Gastro-oesophageal reflux disease

6.00

6.18

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.94

6.17

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

3.99

6.14

1.2

1.0

—

Neurological diseases

4.52

5.97

1.0

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

5.48

5.96

1.0

—

Vasomotor and allergic rhinitis

9.82

5.95

1.0

1.1

—

Oral corticosteroids

4.03

5.94

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7.77

5.70

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

4.30

5.67

1.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3.84

5.59

1.2

1.0

—

COPD/asthma/ILD related infections

4.48

5.59

1.1

1.0

—

COPD/asthma related infections

4.48

5.59

1.1

1.0

—

Infections, IBD-co-morbidities

+∞

5.46

1.2

0.0

—

Episodal and paroxysmal disorders

3.77

5.45

1.0

1.1

—

Fever of other and unknown origin

6.43

5.39

1.2

1.0

—

Asthma, unspecified (mode)

13.56

5.32

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

8.95

5.31

1.1

1.0

—

Asthma, unspecified (mode), excluding more controls

13.47

5.30

1.0

—

Medical observation and evaluation for suspected diseases and conditions

8.77

5.23

1.0

—

Liquid cancers, helper endpoint

11.22

5.13

1.1

1.0

—

FESS (DNB20)

13.35

5.07

1.1

1.0

—

Ethmoidectomy

13.35

5.07

1.1

1.0

—

Opioids

3.74

4.92

1.1

1.0

—

Diseases of the ear and mastoid process

3.46

4.89

1.1

—

3.72

4.87

1.1

1.0

—

Diseases of the eye and adnexa

4.42

4.87

1.0

1.1

—

Arthropathies

3.92

4.86

1.1

1.0

—

Any gastric operation

5.85

4.80

1.0

—

GASTRO-related operations

5.85

4.80

1.0

—

Other dorsopathies, not elsewhere classified

3.62

4.74

1.0

1.1

—

Asthma, including avohilmo

3.33

4.61

1.0

1.1

—

Dermatitis and eczema

3.38

4.60

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

7.96

4.60

1.0

—

Other joint disorders

3.84

4.54

1.1

1.0

—

Dorsopathies

3.52

4.53

1.0

1.1

—

Abnormalities of breathing

3.53

4.51

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

3.56

4.40

1.1

—

Soft tissue disorders

3.50

4.28

1.1

1.0

—

Disorders of lacrimal system

5.49

4.27

1.1

1.0

—

Pain in joint

5.47

4.24

1.1

—

Cough

5.48

4.23

1.0

1.1

—

Inflammatory bowel disease treatment related agents

3.25

4.21

1.1

—

Asthma (diagnoses ohter than nonallergic)

3.36

4.17

1.0

1.1

—

Headache

4.79

4.02

1.0

—

Persons encountering health services in other circumstances, wide

3.20

4.01

1.0

1.1

—

Herpesviral [herpes simplex] infections

6.00

3.81

1.0

—

Asthma, hospital admissions , main diagnosis only

3.25

3.77

1.0

1.1

—

4.55

3.71

1.0

1.1

—

Abnormal findings on diagnostic imaging of lung

5.75

3.68

1.0

—

Asthma/COPD (KELA code 203)

3.31

3.62

1.0

1.1

—

Suppurative and unspecified otitis media

4.92

3.57

1.1

—

Disorders of synovium and tendon

4.87

3.53

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

3.04

3.51

1.0

1.1

—

Obesity related asthma

5.30

3.50

1.0

1.1

—

Other disorders of lacrimal gland

5.30

3.50

1.1

1.0

—

Herpesviral [herpes simplex] infections

10.01

3.49

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

3.08

3.48

1.1

—

Triptan medication for migraine, single purchase ok

3.08

3.48

1.1

—

Bronchitis

2.96

3.42

1.0

1.1

—

Chronic diseases of tonsils and adenoids

4.34

3.32

1.0

1.1

—

Acute suppurative otitis media

4.94

3.30

1.1

—

Sleep disorders (combined)

2.88

3.28

1.0

1.1

—

Soft tissue disorders related to use, overuse and pressure

8.57

3.26

1.2

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

7.72

3.25

1.0

—

Accidents

3.13

3.24

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

3.45

3.11

1.1

—

Sleep apnoea, including avohilmo

2.99

3.04

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

3.17

3.03

1.0

—

Other intervertebral disc disorders

3.61

3.01

1.0

1.1

—

Pollen allergy

5.76

2.99

1.0

—

Other specific joint derangements/joint disorders

3.52

2.98

1.1

1.0

—

Diseases of middle ear and mastoid

3.38

2.98

1.1

1.0

—

Bacterial infection, other or unspecified

4.34

2.96

1.1

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

3.11

2.93

1.0

1.1

—

Asthma-related infections

3.47

2.91

1.0

1.1

—

Asthma, hospital admission 2, infections

3.47

2.91

1.0

1.1

—

Persons encountering health services for examination and investigation

5.73

2.91

1.0

—

Zoster [herpes zoster]

6.67

2.86

1.0

—

Other bacterial intestinal infections

6.67

2.86

1.2

1.0

—

Myalgia

6.67

2.86

1.0

—

Other disorders of skin and subcutaneous tissue

3.37

2.79

1.0

—

Cardiovascular diseases

3.39

2.78

1.0

1.1

—

Dorsalgia

2.88

2.76

1.0

1.1

—

Other external causes of accidental injury

2.92

2.75

1.0

—

Any reimbursement code in KELA

4.51

2.74

1.0

—

Sleep apnoea

2.90

2.74

1.0

1.1

—

Examination and observation for other reasons

5.79

2.70

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

6.00

2.69

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.65

2.59

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases

2.64

2.58

1.1

1.0

—

Septicaemia

4.68

2.57

1.3

1.0

—

Other diseases of urinary system

2.71

2.54

1.1

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

5.45

2.54

1.2

1.0

—

Allergic rhinitis

3.56

2.54

1.0

—

Urticaria and erythema

3.46

2.47

1.0

—

Diseases of the musculoskeletal system and connective tissue

4.46

2.47

1.0

—

Other septicaemia

5.25

2.46

1.2

1.0

—

Zoster [herpes zoster]

4.31

2.43

1.0

1.1

—

Bacterial infection, other or unspecified

3.46

2.42

1.1

1.0

—

Other heart diseases, wide

2.59

2.42

1.1

—

Other and unspecified urticaria

5.00

2.40

1.0

—

Other heart diseases

3.26

2.39

1.1

—

Anaemias

5.60

2.39

1.2

1.1

—

ILD medications: immunosuppressive drugs

3.72

2.38

1.0

1.1

—

Osteopathies and chondropathies

3.35

2.38

1.1

1.0

—

Bacterial intestinal infections, IBD co-morbidities

6.25

2.37

1.2

1.0

—

Finngen Rheumatological endpoints

2.57

2.33

1.0

1.1

—

Asthma-related pneumonia

4.61

2.26

1.0

—

Asthma-related pneumonia or sepsis

4.61

2.26

1.0

—

Asthma, hospital admissions 3, pneumonia

4.61

2.26

1.0

—

Bacterial pneumonia (organism specified)

3.97

2.25

1.0

—

Parasetamol

3.51

2.24

1.0

—

Symptoms and signs involving the urinary system

2.79

2.23

1.1

1.0

—

5.73

2.22

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

3.47

2.22

1.0

1.1

—

Other bacterial intestinal infections

5.56

2.21

1.2

1.0

—

Implicit viral Sepsis

5.56

2.21

1.0

—

Viral Sepsis

5.56

2.21

1.0

—

Ganglion

5.56

2.21

1.0

1.1

—

Other diseases of blood and blood-forming organs, wide

5.56

2.21

1.2

1.0

—

Dermatitis

3.09

2.21

1.0

1.1

—

Coxibs

5.27

2.20

1.0

1.2

—

Artrosis, including avohilmo

2.87

2.18

1.0

1.1

—

Systemic connective tissue disorders

3.69

2.15

1.1

1.0

—

COPD, hospital admission 2, with asthma infections

5.36

2.11

1.0

—

Low back pain

3.08

2.11

1.0

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

5.34

2.10

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.98

2.10

1.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

5.00

2.07

1.0

1.1

—

Mycoses

5.00

2.07

1.0

—

Intestinal infectious diseases

2.32

2.07

1.1

1.0

—

Pulmonary heart disease

5.00

2.07

1.2

1.0

—

Pulmonary embolism

5.00

2.07

1.2

1.0

—

Obesity due to excess calories

2.90

2.07

1.1

—

Used for control exclusion in common control thyroid runs

2.44

2.06

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

4.00

2.04

1.2

1.0

—

Other and unspecified dermatitis

3.08

2.01

1.0

1.1

—

Autoimmune diseases related-to ILD

2.54

2.01

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.99

2.00

1.1

—

Explicit Sepsis

3.44

2.00

1.3

1.0

—

Symptoms and signs involving the digestive system and abdomen

2.61

2.00

1.0

—

Injuries to the shoulder and upper arm

2.53

1.97

1.1

—

All influenza

4.55

1.94

1.0

—

Haemorrhoids and perianal venous thrombosis

4.54

1.93

1.2

1.0

—

Premature rupture of membranes

3.90

1.90

1.0

—

Arthrosis

2.90

1.90

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

3.17

1.87

1.0

—

Autoimmune diseases

2.30

1.85

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2.40

1.85

1.1

—

Nonsuppurative otitis media

4.33

1.83

1.0

—

Gonarthrosis

3.04

1.83

1.0

1.1

—

Other acute lower respiratory infections

2.82

1.82

1.0

—

Maternal care for other known or suspected fetal problems

3.80

1.82

1.2

1.0

—

Mycoses

2.39

1.80

1.0

1.1

—

Acute bronchitis

3.46

1.80

1.0

—

Visual disturbances and blindness

2.76

1.79

1.1

1.0

—

Other diseases of intestines

2.21

1.77

1.1

—

Cardiac arrhythmias

2.66

1.77

1.1

—

Other chronic obstructive pulmonary disease

4.12

1.76

1.0

—

COPD

4.09

1.74

1.0

—

Covid-19 confirmed case

3.33

1.74

1.3

1.0

—

Shoulder lesions

2.85

1.73

1.1

—

Benign neoplasms

2.36

1.73

1.0

1.1

—

Urticaria

2.92

1.72

1.0

—

Other enthesopathies

3.85

1.71

1.0

1.1

—

Gastrointestinal diseases

3.19

1.69

1.0

1.1

—

Atrial fibrillation and flutter

4.05

1.67

1.2

1.1

—

Any event in cancer register

2.28

1.64

1.1

—

Other systemic involvement of connective tissue

3.57

1.61

1.2

1.0

—

DVT of lower extremities and pulmonary embolism

3.56

1.61

1.2

1.0

—

Abdominal and pelvic pain

2.40

1.60

1.0

—

Heart failure and bmi 25plus

3.75

1.58

1.2

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

3.54

1.58

1.0

—

Malignant neoplasm

2.32

1.57

1.1

1.0

—

Exposure to unspecified factor

2.16

1.54

1.1

—

Lyme disease

3.33

1.52

1.0

—

Persons encountering health services for specific procedures and health care

2.11

1.51

1.0

1.1

—

Visual disturbances

2.59

1.51

1.0

—

Other headache syndromes

2.85

1.50

1.0

1.1

—

Benign neoplasm: Colon

2.86

1.50

1.0

1.1

—

Nerve, nerve root and plexus disorders

2.16

1.49

1.0

1.1

—

Bacterial Sepsis

3.29

1.47

1.2

1.0

—

Rotator cuff syndrome

2.87

1.45

1.2

1.1

—

Other disorders of eyelid

3.17

1.45

1.0

—

Codeine

2.36

1.45

1.1

1.0

—

Irregular menses

2.37

1.44

1.1

1.0

—

Obesity

2.35

1.44

1.1

—

Malignant neoplasm, wide definition for exclusion

2.22

1.44

1.1

—

Obesity and other hyperalimentation

2.34

1.44

1.1

—

Spirochaetal infections, other/unspecified

3.13

1.44

1.0

—

Other spirochaetal diseases

3.13

1.44

1.0

—

Other spirochaetal diseases

3.13

1.44

1.0

—

Gonarthrosis [arthrosis of knee](FG)

2.38

1.43

1.0

—

Heart failure,strict

3.21

1.40

1.2

1.0

—

Other nutritional deficiencies

2.23

1.38

1.1

—

Polycystic ovarian syndrome, consortium definition

2.17

1.38

1.1

1.0

—

Neoplasms

2.30

1.37

1.0

1.1

—

COPD, hospital admissions

3.02

1.36

1.0

—

COPD, early/later onset

3.01

1.36

1.0

—

Disturbances of skin sensation

2.94

1.36

1.0

—

Complications of procedures, not elsewhere classified

2.18

1.35

1.0

1.1

—

External causes of morbidity and mortality

2.25

1.34

1.0

1.1

—

Dyspnoea

2.17

1.32

1.0

1.1

—

Heart failure, not strict

2.47

1.32

1.1

1.0

—

Pain in limb

2.43

1.31

1.0

—

Inflammatory diseases of female pelvic organs

2.13

1.30

1.1

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.40

1.30

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

2.39

1.30

1.0

1.1

—

Infections of the skin and subcutaneous tissue

2.33

1.28

1.1

—

Dental pulpitis, including avohilmo

2.00

1.27

1.0

1.1

—

Missing teeth due to accident, extraction or parodontitis

2.46

1.27

1.0

—

Intestinal infectious diseases

2.04

1.26

1.1

1.0

—

Other diseases of lip and oral mucosa

2.40

1.24

1.0

—

Lumbar disc prolapse

2.42

1.22

1.0

1.1

—

Disorders of refraction and accommodation

2.62

1.21

1.0

—

Malaise and fatigue

2.68

1.21

1.0

—

Persons encountering health services in other circumstances

2.62

1.21

1.0

—

Cystitis

2.12

1.20

1.2

1.0

—

Other disorders of urethra and urinary system

2.14

1.18

1.0

—

All chronic kidney diseases

2.34

1.18

1.2

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.98

1.17

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

2.58

1.16

1.0

—

Pain (limb, back, neck, head abdominally)

2.50

1.16

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2.50

1.15

1.0

—

Acute tubulo-interstitial nephritis

2.03

1.13

1.1

1.0

—

Renal tubulo-interstitial diseases

2.01

1.12

1.1

—

All-cause Heart Failure

2.52

1.11

1.2

1.0

—

Heart failure, strict

2.52

1.11

1.2

1.0

—

Spondylopathies

2.32

1.11

1.1

—

Female infertility, cervical, vaginal, other or unspecified origin

2.50

1.09

1.0

—

Cholecystectomy

1.97

1.09

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.95

1.08

1.1

—

Other disorders of ear

1.98

1.06

1.1

1.0

—

Disorders of skin appendages

2.12

1.05

1.1

1.0

—

Codes for special purposes

2.12

1.05

1.3

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.12

1.05

1.3

1.0

—

Hypertensive diseases (excluding secondary)

2.14

1.04

1.0

1.1

—

Solid cancers, helper endpoint

1.97

1.03

1.0

—

Lower back pain or/and sciatica

1.89

1.03

1.0

1.1

—

Dermatophytosis

2.06

1.02

1.0

1.1

—

Other bacterial diseases

1.89

1.02

1.2

1.0

—

Dental operations

2.11

1.01

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

1.90

1.01

1.0

1.1

—

Tramadol

2.05

0.99

1.0

—

Injury, poisoning and certain other consequences of external causes

2.06

0.99

1.0

1.1

—

Other bacterial diseases

1.92

0.99

1.2

1.0

—

Venous thromboembolism

2.19

0.99

1.2

1.0

—

Postpartum haemorrhage

0.00

0.99

0.0

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.83

0.98

1.0

1.1

—

Atopic dermatitis

1.98

0.98

1.0

1.1

—

Contact with and exposure to communicable diseases

0.00

0.97

0.0

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

0.00

0.97

0.0

1.0

—

Cholelithiasis

1.82

0.97

1.1

—

Alcohol use disorder, Swedish definition

0.00

0.96

0.0

1.0

—

Excessive, frequent and irregular menstruation

2.35

0.96

1.0

—

Endocrine, nutritional and metabolic diseases

1.86

0.94

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.88

0.92

1.0

1.1

—

Migraine

2.11

0.90

1.0

1.1

—

Noninflammatory disorders of female genital tract

2.15

0.90

1.0

—

Other functional intestinal disorders

2.06

0.89

1.0

—

Gonarthrosis,primary

1.89

0.88

1.0

1.1

—

Polyarthropathies

2.06

0.88

1.2

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

1.83

0.86

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.80

0.85

1.1

1.0

—

Artificial joint operation, meniscal resection

1.79

0.84

1.0

1.1

—

Single spontaneous delivery

0.00

0.83

0.0

1.1

—

Carpal tunnel syndrome

1.89

0.82

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.78

0.81

1.1

1.0

—

Malignant neoplasm of breast, HER2-negative

0.00

0.80

0.0

1.1

—

Schizophrenia or delusion, excluding more controls

0.00

0.79

0.0

1.0

—

Medicines for HER+ breast cancer

0.00

0.79

0.0

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.82

0.79

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

0.00

0.79

0.0

1.0

—

Female infertility

2.34

0.79

1.0

—

All kidney diseases

1.75

0.78

1.1

—

Neurotic, stress-related and somatoform disorders

1.75

0.78

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.00

0.78

0.0

1.0

—

Cholelithiasis, broad definition with cholecystitis

1.78

0.78

1.1

—

Hypertensive diseases

1.75

0.77

1.0

—

Hypertension

1.75

0.77

1.0

—

Postpartum hemorraghe, parous women as controls

0.00

0.77

0.0

1.0

—

Postpartum hemorraghe, all women as controls

0.00

0.77

0.0

1.0

—

Depression or dysthymia

1.93

0.76

1.1

—

Diseases of arteries, arterioles and capillaries

2.17

0.76

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.89

0.75

1.0

1.1

—

Other arrhythmias

1.89

0.74

1.0

—

Recurrent or chronic depression

2.07

0.74

1.2

1.1

—

Benzodiazepine use

1.63

0.73

1.0

1.1

—

Anxiety disorders, excluding more controls

1.63

0.73

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.80

0.72

1.0

1.1

—

Biguanides

1.61

0.72

1.0

1.1

—

Anxiety disorders

1.70

0.72

1.0

1.1

—

Disease of hard tissues of teeth, NOS

2.01

0.72

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.73

0.70

1.1

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.58

0.70

1.1

—

Chronic apical periodontitis

1.65

0.69

1.0

1.1

—

Hernia of abdominal wall

1.85

0.68

1.0

—

Complications of medical and surgical care

1.65

0.67

1.0

1.1

—

Diabetes, varying definitions

1.67

0.67

1.1

—

Diabetes mellitus

1.67

0.66

1.1

—

Antihypertensive medication - note that there are other indications

1.70

0.64

1.1

1.0

—

Hypertension, essential

1.68

0.64

1.1

1.0

—

Disorders of lens

1.73

0.63

1.2

1.1

—

Varicose veins

1.72

0.63

1.0

—

Pregnancy with abortive outcome

1.61

0.62

1.0

1.1

—

Injuries to the hip and thigh

0.00

0.60

0.0

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

0.00

0.60

0.0

1.1

—

Alcohol use disorder, ICD-based

0.00

0.60

0.0

1.1

—

Non-selective monoamine reuptake inhibitors

0.00

0.59

0.0

1.0

—

Schizophrenia or delusion

0.00

0.59

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.59

0.0

1.0

—

Sensorineural hearing loss

1.77

0.59

1.0

—

Diabetes mellitus in pregnancy

1.75

0.58

1.2

1.0

—

Gestational diabetes (for exclusion)

1.74

0.58

1.2

1.0

—

Disorders of breast

1.76

0.58

1.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.68

0.57

1.0

—

Type 2 diabetes, wide definition

1.67

0.57

1.0

—

Other (not insulin) diabetes medications

1.57

0.56

1.0

1.1

—

Type 2 diabetes

1.55

0.56

1.1

—

Necrosis of pulp, including avohilmo

1.62

0.55

1.0

1.1

—

Diabetes medication

1.48

0.54

1.0

1.1

—

Use of hypnotics and sedatives

1.48

0.54

1.0

1.1

—

Second line medication for Crohn's disease

1.58

0.54

1.0

1.1

—

L04AX Other immunosuppressants

1.58

0.54

1.0

1.1

—

Conductive and sensorineural hearing loss

1.56

0.53

1.0

—

Falls/tendency to fall

1.53

0.53

1.1

—

Injuries to the wrist and hand

1.45

0.53

1.0

1.1

—

Dental caries, including avohilmo

1.63

0.51

1.0

1.1

—

Caries of dentine, including avohilmo

1.63

0.51

1.0

1.1

—

Injuries to the knee and lower leg

1.49

0.49

1.1

1.0

—

Triptan medication for migraine, min. 3 purchases

1.53

0.48

1.1

1.0

—

Exposure to other specified factors

1.43

0.46

1.0

1.1

—

Codeine or tramadol medication

1.48

0.44

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.63

0.43

1.0

—

Polyp of the female genital tract

0.00

0.42

0.0

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.40

0.42

1.0

1.1

—

Insulin medication

1.56

0.42

1.0

1.1

—

Outcome of delivery

0.00

0.42

0.0

1.0

—

Myocardial infarction, strict

0.00

0.42

0.0

1.1

—

Myocardial infarction

0.00

0.42

0.0

1.1

—

Malignant neoplasm of breast, HER-positive

0.00

0.41

0.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.41

0.0

1.1

—

L02BG Aromatase inhibitors

0.00

0.41

0.0

1.1

—

Migraine without aura and triptan purchases

0.00

0.41

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.41

0.0

1.1

—

Bipolar affective disorders

0.00

0.41

0.0

1.1

—

Coxarthrosis, primary, with hip surgery

0.00

0.41

0.0

1.0

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.40

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.40

0.0

1.1

—

Nonorganic sleeping disorders, excluding more controls

0.00

0.40

0.0

1.1

—

Poisoning by drugs, medicaments and biological substances

0.00

0.40

0.0

1.0

—

Perineal laceration during delivery

0.00

0.40

0.0

1.1

—

Abnormalities of heart beat

0.00

0.40

0.0

1.1

—

Disorders of the thyroid gland

1.34

0.40

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.34

0.40

1.0

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.40

0.0

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.45

0.40

1.0

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.00

0.40

0.0

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.43

0.39

1.0

1.1

—

Suicide or other Intentional self-harm

0.00

0.39

0.0

1.0

—

Spontaneous abortion

1.40

0.38

1.0

1.1

—

Pain in throat and chest

1.39

0.35

1.0

1.1

—

Disorders of choroid and retina

1.33

0.34

1.0

1.1

—

Dizziness and giddiness

1.32

0.33

1.0

1.1

—

All anxiety disorders

1.32

0.33

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

1.29

0.32

1.0

1.1

—

Hernia

1.30

0.31

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

1.28

0.30

1.1

—

Type 2 diabetes, definitions combined

1.28

0.30

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.27

0.30

1.1

—

Disorders of conjunctiva

1.28

0.30

1.0

1.1

—

Mood disorders, excluding more controls

1.33

0.29

1.1

—

Depression

1.32

0.28

1.1

1.0

—

Mood [affective] disorders

1.23

0.27

1.1

1.0

—

Fall on same level

1.33

0.27

1.1

1.0

—

Mood disorders

1.23

0.27

1.1

1.0

—

Any mental disorder

1.22

0.26

1.0

1.1

—

Other neurological diseases

1.35

0.23

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.30

0.23

1.2

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.31

0.23

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.28

0.23

1.0

1.1

—

Implicit Sepsis

1.26

0.22

1.0

—

Hypothyroidism, levothyroxine purchases

0.00

0.22

0.0

1.1

—

Hypothyroidism and >3 levothyroxin purchases

0.00

0.22

0.0

1.1

—

Any dementia

0.00

0.22

0.0

1.0

—

Allergic conjunctivitis

1.22

0.22

1.0

1.1

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.21

0.0

1.0

—

Disorders of parathyroid gland

0.00

0.21

0.0

1.0

—

Personal history of other diseases and conditions

0.00

0.21

0.0

1.0

—

Eating disorder

0.00

0.21

0.0

1.0

—

Eating disorders

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

0.21

0.0

1.1

—

Spondyloarthritis

0.00

0.21

0.0

1.0

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.21

0.0

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.21

0.0

1.0

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.21

0.0

1.0

—

Nontoxic multinodular goitre

0.00

0.21

0.0

1.0

—

Sequelae with surgical and medical care as external cause

0.00

0.21

0.0

1.0

—

Fracture of skull and facial bones

0.00

0.21

0.0

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

0.00

0.21

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.21

0.0

1.0

—

Sequelae of external causes of morbidity and mortality

0.00

0.21

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.00

0.21

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

1.0

—

Alcohol dependence

0.00

0.21

0.0

1.0

—

Myocardial infarction, without ST-elevation

0.00

0.21

0.0

1.0

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.21

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.21

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

0.21

0.0

1.0

—

Sulfasalazine

0.00

0.21

0.0

1.0

—

Other diseases of the digestive system

0.00

0.21

0.0

1.0

—

GI-bleeding

0.00

0.21

0.0

1.0

—

Prolonged pregnancy

0.00

0.21

0.0

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.21

0.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

0.21

0.0

1.1

—

Poisoning by medicine

0.00

0.21

0.0

1.0

—

Pedal cyclist injured in transport accident

0.00

0.21

0.0

1.0

—

Primary coxarthrosis, bilateral

0.00

0.21

0.0

1.0

—

Epilepsy

0.00

0.21

0.0

1.0

—

Medical abortion

1.25

0.20

1.0

1.1

—

Tonsillectomy and adenotomy

1.27

0.20

1.0

—

Nonorganic sleeping disorders

0.00

0.20

0.0

1.0

—

Migraine without aura

0.00

0.20

0.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.21

0.20

1.0

—

Conjunctivitis

1.16

0.19

1.0

1.1

—

Metabolic disorders

1.22

0.18

1.0

1.1

—

Insomnia

1.19

0.18

1.0

1.1

—

Sleep disorders

1.18

0.18

1.0

1.1

—

Percutaneous Coronary Intervention

1.13

0.10

1.0

1.1

—

Coronary revascularization (ANGIO or CABG)

1.13

0.10

1.0

1.1

—

Hypothyroidism, strict autoimmune

1.13

0.10

1.2

1.0

—

Ischemic heart diseases

1.11

0.10

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

1.11

0.10

1.0

1.1

—

Emergency coronary revascularization (for ACS)

1.09

0.10

1.0

1.1

—

Major coronary heart disease event

1.08

0.09

1.0

1.1

—

Caries of enamel

0.82

0.08

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.78

0.08

1.2

1.0

—

Injuries to the head

0.80

0.08

1.0

1.1

—

Agranulocytosis

0.00

0.0

1.0

—

Superficial injury of hip and thigh

0.00

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

0.0

1.0

—

Other puerperal infections

0.00

0.0

1.0

—

Alzheimer disease

0.00

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

0.0

1.0

—

Bell's palsy

0.00

0.0

1.0

—

Schizophrenia

0.00

0.0

1.0

—

Retinal vascular occlusion

0.00

0.0

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

0.0

1.0

—

Benign neoplasm: Ascending colon

0.00

0.0

1.0

—

Other and/or unspecified nontoxic goitre

0.00

0.0

1.0

—

Hypothyroidism, other/unspecified

0.89

0.00

1.2

1.0

—

Parkinson's disease, strict definition

0.00

0.0

1.0

—

Methotrexate

0.00

0.0

1.0

—

Noninfectious colitis NAS

0.00

0.0

1.0

—

Acute gastritis

0.00

0.0

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.0

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

1.0

—

Amenorrhoea

0.00

0.0

1.0

—

Hyperparathyroidism

0.00

0.0

1.0

—

Retinal vascular disorders

0.00

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

0.0

1.0

—

Abnormal findings on diagnostic imaging of other body structures

0.00

0.0

1.0

—

Deep bite

0.00

-0.00

0.0

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Enthesopathies of lower limb, excluding foot

0.00

-0.00

0.0

1.0

—

Other disorders of bladder

0.00

-0.00

0.0

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.99

-0.00

1.0

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

-0.00

0.0

1.0

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.0

—

Coronary artery bypass grafting

0.00

-0.00

0.0

1.0

—

Placenta praevia

0.00

-0.00

0.0

1.0

—

Other metabolic disorders

0.00

-0.00

0.0

1.0

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

-0.00

0.0

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Disorders of optic nerve and visual pathways

0.00

-0.00

0.0

1.0

—

DVT of lower extremities

0.00

-0.00

0.0

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.0

—

Acute appendicitis, with complications

0.00

-0.00

0.0

1.0

—

Other problems related to primary support group, including family circumstances

0.00

-0.00

0.0

1.0

—

Family history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders

0.00

-0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Restless leg syndrome

0.00

-0.00

0.0

1.0

—

Fracture of lumbar spine and pelvis

0.00

-0.00

0.0

1.0

—

Ulcerative rectosigmoiditis

0.00

-0.00

0.0

1.0

—

Impacted cerumen

0.00

-0.00

0.0

1.0

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

1.0

—

Other disorders of cornea

0.00

-0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.0

—

Primary hyperparathyroidism

0.00

-0.00

0.0

1.0

—

Fracture of femur

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

-0.00

0.0

1.0

—

Other condition

0.00

-0.00

0.0

1.0

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

1.0

—

Mandibular retrognathia

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

-0.00

0.0

1.0

—

Gingivitis and periodontal diseases

0.86

-0.00

1.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Bitten or struck by other mammals

0.00

-0.00

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

-0.00

0.0

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

-0.00

0.0

1.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Deep endometriosis

0.00

-0.00

0.0

1.0

—

Open wound of ankle and foot

0.00

-0.00

0.0

1.0

—

Gastroduodenal ulcer

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at hip and thigh level

0.00

-0.00

0.0

1.0

—

Chronic periodontitis, including avohilmo

0.86

-0.00

1.2

1.1

—

Seropositive rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

1.0

—

Complications of labour and delivery

0.93

-0.00

1.0

1.1

—

Congenital malformations of genital organs

0.00

-0.00

0.0

1.0

—

Superficial injury of thorax

0.00

-0.00

0.0

1.0

—

Graves disease, strict definition

0.00

-0.00

0.0

1.0

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.0

—

Selective serotonin reuptake inhibitors

1.01

-0.00

1.0

1.1

—

L04AD Calcineurin inhibitors

0.00

-0.00

0.0

1.0

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

-0.00

0.0

1.0

—

Other antidepressants

1.00

-0.00

1.0

1.1

—

Other obstructed labour

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of vulva and perineum

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Nephropathy related operations

0.00

-0.00

0.0

1.0

—

Other disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Any dementia, excluding more controls

0.00

-0.00

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.0

—

Other respiratory disorders and diseases

0.00

-0.00

0.0

1.0

—

Gastric ulcer

0.00

-0.00

0.0

1.0

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.0

—

Periodontitis

0.86

-0.00

1.2

1.1

—

Vitamin B12 deficiency anaemia

0.00

-0.00

0.0

1.0

—

Unspecified kidney failure

0.00

-0.00

0.0

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

0.85

-0.00

1.0

1.1

—

Parkinson's disease

0.00

-0.00

0.0

1.0

—

Focal epilepsy

0.00

-0.00

0.0

1.0

—

Macular pucker

0.00

-0.00

0.0

1.0

—

Myocardial infarction, unclassifiable

0.00

-0.00

0.0

1.0

—

Degenerative macular diseases

0.00

-0.00

0.0

1.0

—

Vitreous haemorrhage

0.00

-0.00

0.0

1.0

—

Other peripheral vertigo

0.00

-0.00

0.0

1.0

—

Ménière disease

0.00

-0.00

0.0

1.0

—

Ocular pain

0.00

-0.00

0.0

1.0

—

Other disorders of eye and adnexa

0.00

-0.00

0.0

1.0

—

Other and unspecified vascular occlusions

0.00

-0.00

0.0

1.0

—

Status post-ami

0.00

-0.00

0.0

1.0

—

Other inflammation of eyelid

0.00

-0.00

0.0

1.0

—

Retinal detachment with retinal break

0.00

-0.00

0.0

1.0

—

Emotionally unstable personality disorder

0.00

-0.00

0.0

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.0

—

Focal epilepsy, strict definition

0.00

-0.00

0.0

1.0

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.0

—

Other specified and unspecified personality disorders

0.00

-0.00

0.0

1.0

—

Hypertensive Heart Disease

0.00

-0.00

0.0

1.0

—

Unspecified/other endometriosis

0.00

-0.00

0.0

1.0

—

Psychiatric diseases

0.88

-0.00

1.0

—

Other eating disorders

0.00

-0.00

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

-0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

-0.00

0.0

1.0

—

Degenerative diseases of the nervous system

0.00

-0.00

0.0

1.0

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

-0.00

0.0

1.0

—

Alzheimer disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Other diseases of the respiratory system

0.00

-0.00

0.0

1.0

—

Vestibular neuronitis

0.00

-0.00

0.0

1.0

—

Benign leiomyoma with endometriosis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Stomach

0.00

-0.00

0.0

1.0

—

Benign neoplasm of mouth and pharynx

0.00

-0.00

0.0

1.0

—

Benign neoplasm of breast

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

1.0

—

Use of donepezil

0.00

-0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.00

-0.00

0.0

1.0

—

Use of memantine

0.00

-0.00

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

-0.00

0.0

1.0

—

Parkinson's disease, including avohilmo

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS